Caricamento...
Early Lyme Borreliosis in Patients Treated with Tumour Necrosis Factor-Alfa Inhibitors
The study evaluated the course and outcome of erythema migrans in patients receiving tumour necrosis factor-alpha (TNF-α) inhibitors. Among 4157 adults diagnosed with erythema migrans in the period 2009–2018, 16 (2.6%) patients were receiving TNF-α inhibitors (adalimumab, infliximab, etarnecept, gol...
Salvato in:
| Pubblicato in: | J Clin Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6912410/ https://ncbi.nlm.nih.gov/pubmed/31684103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8111857 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|